|
KDELR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.804500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.108590E-01 |
| Normal-vs-Stage2 |
5.734200E-02 |
| Normal-vs-Stage3 |
6.310400E-02 |
| Normal-vs-Stage4 |
1.025950E-02 |
| Stage1-vs-Stage2 |
3.242800E-01 |
| Stage1-vs-Stage3 |
4.883000E-01 |
| Stage1-vs-Stage4 |
7.492400E-02 |
| Stage2-vs-Stage3 |
6.714200E-01 |
| Stage2-vs-Stage4 |
7.221000E-01 |
| Stage3-vs-Stage4 |
3.919400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.161600E-02 |
| Normal-vs-AfricanAmerican |
1.396140E-03 |
| Normal-vs-Asian |
1.057570E-01 |
| Caucasian-vs-AfricanAmerican |
4.718300E-02 |
| Caucasian-vs-Asian |
7.755400E-01 |
| AfricanAmerican-vs-Asian |
3.341800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.043900E-03 |
| Normal-vs-Female |
1.203980E-01 |
| Male-vs-Female |
1.543950E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.468000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.794200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.830500E-02 |
| Normal-vs-Age(81-100Yrs) |
3.809600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.432800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.721040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.970600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.819800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.616400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.125000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.501600E-02 |
| Classical-VS-Follicular |
1.989610E-01 |
| Classical-VS-Other |
6.843400E-01 |
| Classical-VS-Normal |
8.915400E-03 |
| Tall-VS-Follicular |
5.676800E-01 |
| Tall-VS-Other |
6.088400E-01 |
| Tall-VS-Normal |
6.320000E-01 |
| Follicular-VS-Other |
9.232000E-01 |
| Follicular-VS-Normal |
2.894400E-01 |
| Other-VS-Normal |
4.761200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.790320E-02 |
| Normal-vs-N1 |
7.504200E-01 |
| N0-vs-N1 |
4.839600E-03 |
|
|
